Details for New Drug Application (NDA): 088713
✉ Email this page to a colleague
The generic ingredient in HY-PAM 25 is hydroxyzine pamoate. There are nineteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.
Summary for 088713
Tradename: | HY-PAM 25 |
Applicant: | Teva |
Ingredient: | hydroxyzine pamoate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 25MG HYDROCHLORIDE | ||||
Approval Date: | Mar 4, 1985 | TE: | RLD: | No |
Complete Access Available with Subscription